Skip to main content

Table 3 The prevalence of mutations in Dhps 540 and Dhps 581 in the different study sites

From: Markers of sulfadoxine–pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention

 

Baraka

Kimbi

Walikale

Mweso

Clinic

Clinic

Clinic

Clinic

N

302

352

365

174

Dhps 540, % (n)

 Wildtype

29.8 (90)

49.7 (175)

21.1 (77)

12.1 (21)

 Pure mutant

56.6 (171)

25.0 (88)

61.9 (226)

75.3 (131)

 Mixed

13.6 (41)

25.3 (89)

17.0 (62)

12.6 (22)

N

314

360

377

178

Dhps 581, % (n)

 Wildtype

78.0 (245)

87.2 (314)

78.8 (297)

52.8 (94)

 Pure mutant

12.1 (38)

4.4 (16)

10.1 (38)

30.3 (54)

 Mixed

9.9 (31)

8.3 (30)

11.1 (42)

16.9 (30)

  1. N total sample size per location, n absolute number, Dhps dihydropteroate synthase